Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Endocyte
Endocyte
Wider-than-Expected Loss at Endocyte
Yahoo/Zacks
Sat, 08/3/13 - 10:28 am
Endocyte
earnings
Merck Needs Acquisitions: Here's The List
Seeking Alpha
Tue, 07/23/13 - 12:07 pm
Merck
M&A
Celgene
Dendreon
Endocyte
Immunomedics
Isis Pharmaceuticals
Vical
ONYX Pharmaceuticals
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Fri, 04/5/13 - 10:21 am
Merck
Endocyte
Eli Lilly
Pfizer
Repligen
AbbVie
Protalix BioTherapeutics
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 03/30/13 - 10:38 am
Repros Therapeutics
Endocyte
Sarepta Therapeutics
Endocyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Tue, 02/26/13 - 10:09 am
earnings
Endocyte
2 Speculative Cancer Plays
Seeking Alpha
Mon, 01/21/13 - 10:52 am
Endocyte
Geron
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Yahoo/AP
Tue, 11/27/12 - 01:08 pm
Merck
Endocyte
Europe
vintafolide
ovarian cancer
Endocyte Reports Third Quarter 2012 Financial Results and Business Update
Yahoo
Thu, 11/1/12 - 06:07 pm
earnings
Endocyte
4 Low-Debt Pharmaceutical Stocks Backed By Analysts
Seeking Alpha
Wed, 08/29/12 - 10:35 am
Endocyte
Astex
Rigel Pharmaceuticals
Impax Labs
Johnson & Johnson releases some Doxil for trials
Fierce Pharma
Fri, 08/3/12 - 11:32 am
Doxil
JNJ
cancer
clinical trials
Boehringer Ingelheim
Endocyte
Endocyte, Inc's CEO Discusses Second Quarter Results - Earnings Call Transcript
Seeking Alpha
Fri, 08/3/12 - 09:16 am
earnings
Endocyte
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Merck
Singulair
Pfizer
AstraZeneca
Sanofi
Forest Labs
Bristol-Myers Squibb
suvorexant
Eli Lilly
Bridon
V503
Endocyte
Tredaptive
Endocyte Reports First Quarter 2012 Financial Results and Operations Update
Yahoo
Fri, 05/11/12 - 11:24 am
Endocyte
earnings
Understanding The Prospects Of Endocyte
Seeking Alpha
Tue, 05/1/12 - 07:14 am
Endocyte
Merck
Endocyte Scores With Merck Partnership
Seeking Alpha
Sun, 04/22/12 - 12:13 pm
Endocyte
Merck
vintafolide
ovarian cancer
non-small cell lung cancer
Endocyte Gets Big Deal But More Validation Needed
Seeking Alpha
Wed, 04/18/12 - 11:39 am
Merck
Endocyte
EC145
ovarian cancer
Endocyte Doubles on Ovarian Drug Partnership With Merck
Bloomberg
Mon, 04/16/12 - 11:28 am
Merck
Endocyte
vintafolide
ovarian cancer
Early Submission = 60% Pop
Motley Fool
Sat, 03/17/12 - 10:34 am
Endocyte
EC145
ovarian cancer
Pages
« first
‹ previous
1
2
3
4
next ›
last »